Drug · DIN 02460106
FYCOMPA
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since February 24, 2023.
- Drug Identification Number (DIN)
- 02460106
- Company (DIN owner)
- Eisai LimitedWoodcliff Lake, New Jersey, United States
- Schedule
- Prescription
- Dosage form
- Suspension
- Route
- Oral
- Therapeutic class (ATC)
- Perampanel N03AX22
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PERAMPANEL | 0.5 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 21, 2016: NOC 18795Supplement to a New Drug Submission (SNDS) · Adding an oral suspension as a new formulation
Other DINs named FYCOMPA
- DIN 02404516 · Marketed
- DIN 02404524 · Marketed
- DIN 02404532 · Marketed
- DIN 02404540 · Marketed
- DIN 02404559 · Marketed
- DIN 02404567 · Marketed